A nurse is assessing a patient with active pulmonary tuberculosis who has been on anti-tuberculosis therapy for 6 weeks. The patient reports persistent fatigue, nausea, and yellowing of the eyes. Laboratory results show elevated liver enzymes (ALT 180 U/L, AST 200 U/L). What is the most appropriate nursing intervention?

The patient shows signs of drug-induced hepatotoxicity from anti-tuberculosis medications. Immediate discontinuation of hepatotoxic drugs and physician notification are critical, while other options delay necessary intervention.

Core Nursing Explanation Key Concept Analysis: This question assesses the nurse's ability to recognize and prioritize a critical adverse effect of anti-tuberculosis therapy: drug-induced hepatotoxicity. The standard first-line regimen for active pulmonary tuberculosis (TB) includes Isoniazid (INH), Rifampin (RIF), Pyrazinamide (PZA), and Ethambutol (EMB). A key side effect of INH, RIF, and PZA is hepatotoxicity. The patient's symptoms (fatigue, nausea, jaundice/yellowing eyes) and significantly elevated liver enzymes (ALT 180 U/L, AST 200 U/L; normal is typically 7-56 U/L) are classic signs of liver injury. The nurse's primary role is patient safety and preventing further harm.

Answer Rationale: Key Point! The most appropriate and immediate nursing action is to hold (discontinue) the hepatotoxic medications and notify the physician. This is a standard protocol for suspected severe drug-induced liver injury. Continuing the drugs could lead to fulminant hepatic failure. The physician must be notified to order definitive lab tests (e.g., bilirubin, INR), assess the severity, and decide on an alternative treatment regimen. This action aligns with the nursing principle of preventing harm.

Distractor Analysis: Watch out for confusion! Option ① (Continue and monitor weekly) is dangerous because it delays necessary intervention while the patient's liver is actively being damaged. Monitoring is important, but not when acute, symptomatic hepatotoxicity is present.
Option ② (Reduce dosage by half) is incorrect because dosage adjustment is not within the nurse's independent scope of practice for high-risk medications like anti-TB drugs. Furthermore, the problem is likely the drug's inherent toxicity, not just the dose.
Option ④ (Add hepatoprotective supplements) is inappropriate as it does not address the root cause—the ongoing assault from the offending drugs. Supplements like milk thistle are not a substitute for stopping the causative agents in an acute setting.

Related Concepts: Management of drug-induced hepatotoxicity involves stopping the offending agent, supportive care, and close monitoring. For TB, therapy may be restarted with a modified, less hepatotoxic regimen once liver function recovers, or alternative second-line drugs may be used. Patient education on recognizing symptoms of hepatotoxicity (jaundice, dark urine, fatigue, anorexia) is a crucial part of TB treatment.

Concept Summary

Concept	Key Points
Anti-TB Drug Hepatotoxicity	Common with INH, RIF, PZA. Presents with fatigue, nausea, jaundice, elevated ALT/AST.
Nursing Priority	Stop the drug, notify MD. Safety first. Do not adjust dose or add supplements independently.
Monitoring	Baseline LFTs (Liver Function Tests) before starting therapy and periodic monitoring, especially if symptoms arise.
Patient Education	Teach signs of liver damage: yellow skin/eyes, dark urine, clay-colored stools, severe fatigue, loss of appetite.

Side-by-Side Comparison!

Action	Appropriate Scenario	Inappropriate Scenario
Hold meds & notify MD	Suspected severe adverse reaction (anaphylaxis, hepatotoxicity, Stevens-Johnson syndrome).	Minor, expected side effect (orange urine from Rifampin, peripheral neuropathy from INH managed with Pyridoxine).
Continue & monitor	Stable patient on therapy with no signs of toxicity, following routine monitoring schedule.	Patient exhibiting new, serious signs of organ toxicity (as in this case).

Anatomy, Physiology & Pharmacology Points

• Liver Enzymes: ALT (Alanine Aminotransferase) is more specific to the liver. AST (Aspartate Aminotransferase) is found in liver, heart, muscle. Elevation indicates hepatocyte damage.
• Drug Metabolism: Many drugs, including INH and RIF, are metabolized by the liver's cytochrome P450 system. Toxicity can occur due to the drug itself or its metabolites.
• First-Line TB Drugs: Remember the mnemonic RIPE for the initial intensive phase: Rifampin, Isoniazid, Pyrazinamide, Ethambutol.

Memory Tips

• HALT for Hepatotoxicity: Hold the drug, Assess LFTs, Listen to patient symptoms (jaundice, nausea), Tell (notify) the physician.
• Yellow Flag: Any patient on anti-TB drugs who turns yellow (jaundice) is a red flag to stop the drugs.

High-Frequency NCLEX Topics NCLEX loves testing priority actions for adverse drug reactions. Hepatotoxicity from TB meds, ototoxicity/ nephrotoxicity from aminoglycosides, and bone marrow suppression from chemotherapy are classic examples. The rule is almost always: Stop the drug, assess the patient, notify the provider.

Watch Out for Question Variations!

• Instead of asking for the intervention, the question might ask: "Which finding requires immediate notification of the provider in a patient taking Isoniazid?" Answer: Jaundice or elevated LFTs.
• The scenario could shift to peripheral neuropathy from INH (numbness, tingling). The correct intervention would be to administer Pyridoxine (Vitamin B6) as prescribed, not to stop the drug.

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse on a medical-surgical unit. Mr. Chen, 58, is being treated for active pulmonary TB. He has been adherent to his 4-drug regimen for 6 weeks. During your morning assessment, he says he hasn't felt like eating for two days, feels extremely tired, and his sclera have a yellowish tint. You check his most recent lab results and see ALT 180, AST 200.

Nursing Intervention Strategy: 1. Immediate Action: Withhold the scheduled morning doses of INH, RIF, and PZA. (Ethambutol is less hepatotoxic but often held as well per protocol). Document "Medications held due to suspected hepatotoxicity, MD notified." 2. Assessment: Perform a focused assessment. Check vital signs. Assess skin and sclera for jaundice. Palpate the abdomen for liver tenderness. Ask about dark urine or light-colored stools. Assess for confusion (sign of hepatic encephalopathy). 3. Notification: Call the physician or provider immediately. Report using SBAR (Situation, Background, Assessment, Recommendation). "Situation: Mr. Chen, TB patient, shows signs of hepatotoxicity. Background: On RIPE therapy for 6 weeks. Assessment: Jaundice, fatigue, nausea, LFTs elevated to ALT 180. Recommendation: I have held the hepatotoxic meds. Request orders for STAT bilirubin, INR, and further instructions." 4. Patient Care & Monitoring: Ensure patient is on bedrest to reduce metabolic demand on the liver. Monitor for signs of worsening liver failure (increased jaundice, bleeding tendencies, altered mental status). Provide supportive care for nausea. 5. Patient Education: Once stable, explain why the medications were stopped. Reinforce the importance of reporting any future symptoms promptly.

Patient Safety and Precautions:

• Contraindication: Do not restart hepatotoxic TB medications without a physician's order and evidence of recovering liver function.
• Medication Caution: Be aware that many other drugs (e.g., acetaminophen, certain antibiotics) can also stress the liver. A thorough medication reconciliation is essential.
• Key Monitoring: In addition to LFTs, monitor INR (can increase due to impaired synthesis of clotting factors) and bilirubin (direct and indirect).

Nursing Procedure & Medication Flow Procedure for Managing a Suspected Adverse Drug Reaction: 1. Recognize signs/symptoms and correlate with patient's medication list. 2. STOP administering the suspected drug(s). 3. Assess patient's ABCs (Airway, Breathing, Circulation) and vital signs. 4. Notify the prescribing provider/physician immediately. 5. Document actions taken, communication, and patient response. 6. Implement any new orders (e.g., lab draws, antidotes, alternative medications).

Anti-TB Medication Administration Points:

• Isoniazid (INH): Can cause peripheral neuropathy. Pyridoxine (B6) is given prophylactically.
• Rifampin (RIF): Turns body fluids (urine, sweat, tears) orange-red. Warn the patient. Can stain contact lenses.
• Pyrazinamide (PZA): Major cause of hyperuricemia (can precipitate gout) and hepatotoxicity.
• Ethambutol (EMB): Main toxicity is optic neuritis (red-green color blindness, blurred vision). Requires baseline and periodic visual acuity testing.

A Word from Your Senior Nurse "Nursing is not just about carrying out physician orders — it's about being the frontline guardian for your patients! In clinical practice, recognizing subtle changes like a hint of yellow in the sclera or a patient's offhand comment about fatigue can be the early warning sign of a serious problem. When studying for your boards, don't just memorize drug lists — connect each drug to its 'signature' toxicities. Ask yourself, 'If my patient on this drug develops X symptom, what's my first move?' That mindset of linking pharmacology to assessment and action will not only earn you a great score on the NCLEX but will make you a truly confident, professional nurse who catches problems before they become crises!"